These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15014220)

  • 1. Random internal component failure of an implantable cardioverter defibrillator.
    Wase A
    J Interv Card Electrophysiol; 2004 Apr; 10(2):175-6. PubMed ID: 15014220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 3. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery.
    Schloss EJ; Krebs ME; Gupta M
    Heart Rhythm; 2014 Oct; 11(10):1733-4. PubMed ID: 24931635
    [No Abstract]   [Full Text] [Related]  

  • 6. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database.
    Hauser RG; Kallinen L
    Heart Rhythm; 2004 Oct; 1(4):399-405. PubMed ID: 15851191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sudden cardiac death: who benefits from an implantable defibrillator?].
    Sticherling C
    Praxis (Bern 1994); 2005 May; 94(21):869-73. PubMed ID: 15966486
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter defibrillator shock from a transcutaneous muscle stimulation device therapy.
    Siu CW; Tse HF; Lau CP
    J Interv Card Electrophysiol; 2005 Jun; 13(1):73-5. PubMed ID: 15976983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 13. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 14. Inappropriate therapy due to triple counting of the ventricular electrogram in a patient with implantable cardioverter-defibrillator.
    Alasti M; Haghjoo M; Alizadeh A; Fazelifar AF; Sadr-Ameli MA
    Heart Rhythm; 2005 Nov; 2(11):1253-5. PubMed ID: 16253917
    [No Abstract]   [Full Text] [Related]  

  • 15. Twiddler syndrome as a rare cause of implantable cardioverter defibrillator malfunction.
    Gungor H; Duygu H; Yildiz BS; Gul I; Zoghi M; Akin M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):352-3. PubMed ID: 19430349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the wearable cardioverter-defibrillator the answer for early post-myocardial infarction patients at risk for sudden death?: mind the gap.
    Zei PC
    J Am Coll Cardiol; 2013 Nov; 62(21):2008-2009. PubMed ID: 23916931
    [No Abstract]   [Full Text] [Related]  

  • 17. Extreme electrical storm in a patient with an implantable cardioverter defibrillator.
    Sela R; Gellerman M; Kalfon E; Atar S
    Isr Med Assoc J; 2014 Aug; 16(8):513-5. PubMed ID: 25269346
    [No Abstract]   [Full Text] [Related]  

  • 18. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
    Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.